Catalent Pharma Solutions Announces Two Senior Appointments to Drive Growth in China

Published: Apr 17, 2013

Catalent Pharma Solutions today announced that it has made two senior appointments to support its recently established joint ventures in China for its Softgel Technologies and Clinical Supply Solutions (CSS) businesses. Dr. Weiyan “Jackson” Zhu has joined as Catalent's Country General Manager for China, while Yufeng (Paul) Cao becomes the new Site Operations Director, for the 31,000 sq ft Catalent (Shanghai) Clinical Trial Supplies Co., Ltd facility, which is currently under construction. Dr. Zhu and Mr. Cao will both be based in Shanghai.

Back to news